Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Anja Stirnweiss"'
Autor:
Anja Stirnweiss, Hetal Dholaria, Joyce Oommen, Kathy Hardy, Gareth Jevon, Alex H. Beesley, Rishi S. Kotecha
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
An 8-year and 10-month-old boy presented following 2 weeks of abdominal pain, vomiting, constipation, and rectal pain. A diffuse lower-abdominal mass was felt upon palpation, with radiological findings confirming the presence of a large, multilobulat
Externí odkaz:
https://doaj.org/article/e195495a3f034367b0a85ebe1d940f0b
Targeted SMN Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching Studies
Autor:
Loren L. Flynn, Chalermchai Mitrpant, Abbie Adams, Ianthe L. Pitout, Anja Stirnweiss, Sue Fletcher, Steve D. Wilton
Publikováno v:
Biomedicines, Vol 9, Iss 5, p 552 (2021)
The literature surrounding the use of antisense oligonucleotides continues to grow, with new disease and mechanistic applications constantly evolving. Furthermore, the discovery and advancement of novel chemistries continues to improve antisense deli
Externí odkaz:
https://doaj.org/article/c093896f88cb4b6f93e8bc07067c23c7
Autor:
Hansjörg Hauser, Jörg Reimann, Martina Grashoff, Katjana Klages, Julia Elisabeth Pulverer, Anja Stirnweiss, Andrea Kröger
Supplementary Table 1 from Tumor Suppression by IFN Regulatory Factor-1 Is Mediated by Transcriptional Down-regulation of Cyclin D1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0caedaa38c6c256060d310d971fb8013
https://doi.org/10.1158/0008-5472.22371159
https://doi.org/10.1158/0008-5472.22371159
Autor:
Hansjörg Hauser, Jörg Reimann, Martina Grashoff, Katjana Klages, Julia Elisabeth Pulverer, Anja Stirnweiss, Andrea Kröger
IFNs have been ascribed to mediate antitumor effects. IFN regulatory factor-1 (IRF-1) is a major target gene of IFNs. It inhibits cell proliferation and oncogenic transformation. Here, we show that 60% of all mRNAs deregulated by oncogenic transforma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8e35a88423f7445acdd7950e62e8598
https://doi.org/10.1158/0008-5472.c.6496686
https://doi.org/10.1158/0008-5472.c.6496686
Autor:
Hansjörg Hauser, Jörg Reimann, Martina Grashoff, Katjana Klages, Julia Elisabeth Pulverer, Anja Stirnweiss, Andrea Kröger
Supplementary Figure Legends 1-2 from Tumor Suppression by IFN Regulatory Factor-1 Is Mediated by Transcriptional Down-regulation of Cyclin D1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33349db35885b87ab335f59750f4741a
https://doi.org/10.1158/0008-5472.22371162.v1
https://doi.org/10.1158/0008-5472.22371162.v1
Autor:
Hansjörg Hauser, Jörg Reimann, Martina Grashoff, Katjana Klages, Julia Elisabeth Pulverer, Anja Stirnweiss, Andrea Kröger
Supplementary Figure 2 from Tumor Suppression by IFN Regulatory Factor-1 Is Mediated by Transcriptional Down-regulation of Cyclin D1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4255fcf313a5b5ccd5a24f6981bb3158
https://doi.org/10.1158/0008-5472.22371165.v1
https://doi.org/10.1158/0008-5472.22371165.v1
Autor:
Hansjörg Hauser, Jörg Reimann, Martina Grashoff, Katjana Klages, Julia Elisabeth Pulverer, Anja Stirnweiss, Andrea Kröger
Supplementary Figure 1 from Tumor Suppression by IFN Regulatory Factor-1 Is Mediated by Transcriptional Down-regulation of Cyclin D1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5536a4425b65fd75c10338a7da761ecc
https://doi.org/10.1158/0008-5472.22371168
https://doi.org/10.1158/0008-5472.22371168
Autor:
Ben Wylie, Ferrer Ong, Hanane Belhoul-Fakir, Kristin Priebatsch, Heique Bogdawa, Anja Stirnweiss, Paul Watt, Paula Cunningham, Shane R. Stone, Jason Waithman
Publikováno v:
Cancers, Vol 13, Iss 6189, p 6189 (2021)
Cancers
Cancers; Volume 13; Issue 24; Pages: 6189
Cancers
Cancers; Volume 13; Issue 24; Pages: 6189
Simple Summary Cancer vaccination is a potential anti-cancer therapy which may improve clinical outcomes, particularly in combination with current immunotherapies, but to date has demonstrated only limited success. Here we set out to improve the effe
Autor:
Alex H. Beesley, Hetal Dholaria, Rishi S. Kotecha, Kathy Hardy, Gareth Jevon, Joyce Oommen, Anja Stirnweiss
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
An 8-year and 10-month-old boy presented following 2 weeks of abdominal pain, vomiting, constipation, and rectal pain. A diffuse lower-abdominal mass was felt upon palpation, with radiological findings confirming the presence of a large, multilobulat
Publikováno v:
Oncotarget. 8:112313-112329
NUT midline carcinoma (NMC) is a rare and aggressive cancer, with survival typically less than seven months, that can arise in people of any age. Genetically, NMC is defined by the chromosomal fusion of NUTM1 with a chromatin-binding partner, typical